Status:
COMPLETED
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Neonatal Hyperbilirubinemia
Eligibility:
All Genders
Up to 1 years
Brief Summary
We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test res...
Detailed Description
In 2004, the American Academy of Pediatrics disseminated clinical practice guidelines for the management of neonatal hyperbilirubinemia. Using the infant's age in hours, serum bilirubin levels are app...
Eligibility Criteria
Inclusion
- Providers who care for infants in the newborn nursery.
- All newborns in the newborn nursery that are 35 weeks or more weeks of gestation will be study eligible.
Exclusion
- Infants less than 35 weeks gestation.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
273 Patients enrolled
Trial Details
Trial ID
NCT00801619
Start Date
November 1 2008
End Date
December 1 2011
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114